Sphingosine 1-phosphate release from platelets during clot formation: Close correlation between platelet count and serum sphingosine 1-phosphate concentration

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Ono, Yoshikazu ^a,c   Kurano, Makoto ^b   Ohkawa, Ryunosuke ^a   Yokota, Hiromitsu ^a   Igarashi, Koji ^d   Aoki, Junken ^e   Tozuka, Minoru ^c   Yatomi, Yutaka ^a,b  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d TOSOH CORPORATION   (Japan)

^e TOHOKU UNIVERSITY   (Japan)

Author keywords

Autotaxin; Dihydrosphingosine 1 phosphate; Platelets; Red blood cells; Sphingosine 1 phosphate

Indexed keywords

AUTOTAXIN; DIHYDROSPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ERYTHROCYTE COUNT; HEMATOLOGIC DISEASE; HUMAN; THROMBOCYTE COUNT; THROMBOCYTHEMIA;

ANEMIA, APLASTIC; BLOOD COAGULATION; BLOOD PLATELETS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; HUMANS; LYSOPHOSPHOLIPIDS; PHOSPHORIC DIESTER HYDROLASES; PLATELET ACTIVATION; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SPHINGOSINE; THROMBOCYTHEMIA, ESSENTIAL; TRIGLYCERIDES; VON WILLEBRAND DISEASES;

SPHINGOIDEA;

EID: 84873938350     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-20     Document Type: Article

References (27)

1. Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular diseases. Yatomi Y, Curr Pharm Des 2006 12 575 587 10.2174/138161206775474404 16472149
2. Sphingosine 1-phosphate, a key cell signaling molecule. Spiegel S, Milstien S, J Biol Chem 2002 277 25851 25854 10.1074/jbc.R200007200 12011102 (Pubitemid 34967061)
3. Sphingosine-1-phosphate: an enigmatic signalling lipid. Spiegel S, Milstien S, Nat Rev Mol Cell Biol 2003 4 397 407 10.1038/nrm1103 12728273 (Pubitemid 36565571)
4. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. Yatomi Y, Igarashi Y, Yang L, Hisano N, Qi R, Asazuma N, Satoh K, Ozaki Y, Kume S, J Biochem 1997 121 969 973 10.1093/oxfordjournals.jbchem.a021681 9192741 (Pubitemid 27236918)
5. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Pappu R, Schwab SR, Cornelissen I, Pereira JP, Regard JB, Xu Y, Camerer E, Zheng YW, Huang Y, Cyster JG, Coughlin SR, Science 2007 316 295 298 10.1126/science.1139221 17363629 (Pubitemid 46633109)
6. Plasma sphingosine-1-phosphate measurement in healthy subjects: close correlation with red blood cell parameters. Ohkawa R, Nakamura K, Okubo S, Hosogaya S, Ozaki Y, Tozuka M, Osima N, Yokota H, Ikeda H, Yatomi Y, Ann Clin Biochem 2008 45 356 363 10.1258/acb.2007.007189 18583619 (Pubitemid 352031541)
7. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease. Sattler KJ, Elbasan S, Keul P, Elter-Schulz M, Bode C, Graler MH, Brocker-Preuss M, Budde T, Erbel R, Heusch G, Levkau B, Basic Res Cardiol 2010 105 821 832 10.1007/s00395-010-0112-5 20652276
8. S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease. Argraves KM, Sethi AA, Gazzolo PJ, Wilkerson BA, Remaley AT, Tybjaerg-Hansen A, Nordestgaard BG, Yeatts SD, Nicholas KS, Barth JL, Argraves WS, Lipids Health Dis 2011 10 70 10.1186/1476-511X-10-70 21554699
9. Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate. Deutschman DH, Carstens JS, Klepper RL, Smith WS, Page MT, Young TR, Gleason LA, Nakajima N, Sabbadini RA, Am Heart J 2003 146 62 68 10.1016/S0002-8703(03)00118-2 12851609 (Pubitemid 36851301)
10. Sphingosine 1-phosphate-related metabolism in the blood vessel. Aoki S, Yatomi Y, Ohta M, Osada M, Kazama F, Satoh K, Nakahara K, Ozaki Y, J Biochem 2005 138 47 55 10.1093/jb/mvi100 16046448 (Pubitemid 41105153)
11. Sphingosine 1-phosphate is released from the cytosol of rat platelets in a carrier-mediated manner. Kobayashi N, Nishi T, Hirata T, Kihara A, Sano T, Igarashi Y, Yamaguchi A, J Lipid Res 2006 47 614 621 16371645 (Pubitemid 43345602)
12. Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival. Van Brocklyn JR, Lee MJ, Menzeleev R, Olivera A, Edsall L, Cuvillier O, Thomas DM, Coopman PJ, Thangada S, Liu CH, et al. J Cell Biol 1998 142 229 240 10.1083/jcb.142.1.229 9660876 (Pubitemid 28341153)
13. Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator? Okajima F, Biochim Biophys Acta 2002 1582 132 137 10.1016/S1388-1981(02)00147-6 12069820 (Pubitemid 34634121)
14. Sphingosine-1-phosphate: A bioactive lipid that confers high-density lipoprotein with vasculoprotection mediated by nitric oxide and prostacyclin. Rodriguez C, Gonzalez-Diez M, Badimon L, Martinez-Gonzalez J, Thromb Haemost 2009 101 665 673 19350109
15. Two pathways for lysophosphatidic acid production. Aoki J, Inoue A, Okudaira S, Biochim Biophys Acta 2008 1781 513 518 10.1016/j.bbalip.2008.06.005 18621144
16. Biological roles of lysophosphatidic acid signaling through its production by autotaxin. Okudaira S, Yukiura H, Aoki J, Biochimie 2010 92 698 706 10.1016/j.biochi.2010.04.015 20417246
17. Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. Clair T, Aoki J, Koh E, Bandle RW, Nam SW, Ptaszynska MM, Mills GB, Schiffmann E, Liotta LA, Stracke ML, Cancer Res 2003 63 5446 5453 14500380 (Pubitemid 37139863)
18. Sphingosine 1-phosphate and activation of endothelial nitric-oxide synthase. differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells. Igarashi J, Bernier SG, Michel T, J Biol Chem 2001 276 12420 12426 10.1074/jbc.M008375200 11278407
19. Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells. Kimura T, Tomura H, Mogi C, Kuwabara A, Damirin A, Ishizuka T, Sekiguchi A, Ishiwara M, Im DS, Sato K, et al. J Biol Chem 2006 281 37457 37467 10.1074/jbc.M605823200 17046831 (Pubitemid 46042049)
20. The suppressive effect of sphingosine 1-phosphate on monocyte-endothelium adhesion may be mediated by the rearrangement of the endothelial integrins alpha(5)beta(1) and alpha(v)beta(3). Aoki S, Yatomi Y, Shimosawa T, Yamashita H, Kitayama J, Tsuno NH, Takahashi K, Ozaki Y, J Thromb Haemost 2007 5 1292 1301 10.1111/j.1538-7836.2007.02559.x 17403093 (Pubitemid 46902133)
21. Expression of adhesion molecules by sphingosine 1-phosphate and histamine in endothelial cells. Shimamura K, Takashiro Y, Akiyama N, Hirabayashi T, Murayama T, Eur J Pharmacol 2004 486 141 150 10.1016/j.ejphar.2003.12.022 14975703 (Pubitemid 38224525)
22. Globular adiponectin induces adhesion molecule expression through the sphingosine kinase pathway in vascular endothelial cells. Kase H, Hattori Y, Jojima T, Okayasu T, Tomizawa A, Suzuki K, Banba N, Monden T, Satoh H, Akimoto K, Kasai K, Life Sci 2007 81 939 943 10.1016/j.lfs.2007.08.002 17822721 (Pubitemid 47374213)
23. Sphingosine 1-phosphate induces platelet activation through an extracellular action and shares a platelet surface receptor with lysophosphatidic acid. Yatomi Y, Yamamura S, Ruan F, Igarashi Y, J Biol Chem 1997 272 5291 5297 10.1074/jbc.272.8.5291 9030602 (Pubitemid 27090092)
24. Identification of lysophospholipid receptors in human platelets: the relation of two agonists, lysophosphatidic acid and sphingosine 1-phosphate. Motohashi K, Shibata S, Ozaki Y, Yatomi Y, Igarashi Y, FEBS Lett 2000 468 189 193 10.1016/S0014-5793(00)01222-9 10692584 (Pubitemid 30110793)
25. WHO classification of tumours of haematopoietic and lymphoid tissues. Swerdlow SHCE, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, Classification of tumours of haematopoietic and lymphoid tissues IARC Press, Lyon, France, Book WHO, 4 2008 88 93
26. Plasma sphingosine 1-phosphate metabolism and analysis. Yatomi Y, Biochim Biophys Acta 2008 1780 606 611 10.1016/j.bbagen.2007.10.006 17980708 (Pubitemid 351381252)
27. Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation. Nakamura K, Igarashi K, Ide K, Ohkawa R, Okubo S, Yokota H, Masuda A, Oshima N, Takeuchi T, Nangaku M, et al. Clin Chim Acta 2008 388 51 58 10.1016/j.cca.2007.10.005 17963703 (Pubitemid 350266568)